mstockstill on PROD1PC66 with NOTICES


Federal Register / Vol. 74, No. 40 / Tuesday, March 3, 2009 / Notices 9247 

The purpose of this analysis is to 

facilitate public comment on the 

proposed Decision and Order. This 

analysis is not intended to constitute an 

official interpretation of the Consent 

Agreement and the proposed Decision 

and Order, and does not modify their 

terms in any way. Further, the proposed 

Consent Agreement has been entered 

into for settlement purposes only, and 

does not constitute an admission by 

Respondents that they violated the law 

or that the facts alleged in the complaint 

(other than jurisdictional facts) are true. 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. E9–4481 Filed 3–2–09: 8:45 am] 

[BILLING CODE 6750–01–S] 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institute for Occupational 

Safety and Health; Decision To 

Evaluate a Petition To Designate a 

Class of Employees for the Oak Ridge 

Hospital, Oak Ridge, TN, To Be 

Included in the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice as required 

by 42 CFR 83.12(e) of a decision to 

evaluate a petition to designate a class 

of employees for the Oak Ridge 

Hospital, Oak Ridge, Tennessee, to be 

included in the Special Exposure Cohort 

under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. The initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Oak Ridge Hospital. 

Location: Oak Ridge, Tennessee. 

Job Titles and/or Job Duties: All 

employees. 

Period of Employment: June 30, 1958 

through December 31, 1959. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 513– 

533–6800 (this is not a toll-free 

number). Information requests can also 

be submitted by e-mail to 

OCAS@CDC.GOV. 

Christine M. Branche, 

Acting Director, National Institute for 

Occupational Safety and Health. 

[FR Doc. E9–4493 Filed 3–2–09; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention (CDC) 

Request for Nominations of 

Candidates To Serve on the Board of 

Scientific Counselors, Coordinating 

Center for Infectious Diseases (BSC, 

CCID) 

CDC is soliciting nominations for 

possible membership on the BSC, CCID. 

This board provides advice and 

guidance to the Secretary, Department 

of Health and Human Services (HHS), 

the Director, CDC, and the Director, 

CCID, concerning strategies and goals 

for the programs and research within 

the national centers; shall conduct peerreview of scientific programs; and 

monitor the overall strategic direction 

and focus of the national centers. The 

board shall also monitor program 

organization and resources for 

infectious disease prevention and 

control. 

Nominations are being sought for 

individuals who have the expertise and 

qualifications necessary to contribute to 

the accomplishment of the board’s 

objectives. Nominees will be selected by 

the Secretary, HHS, or designee, from 

authorities knowledgeable in the fields 

relevant to the issues addressed by the 

CCID and related disciplines, including: 

Epidemiology; microbiology; 

bacteriology; virology; parasitology; 

mycology; immunology; public health; 

entomology; bioterrorism threats; 

clinical medicine; ecology; and from the 

general public. Federal employees will 

not be considered. Members may be 

invited to serve for terms of up to four 

years. 

Consideration is given to 

representation from diverse geographic 

areas, both genders, ethnic and minority 

groups, and the disabled. Nominees 

must be U.S. citizens. 

The following information must be 

submitted for each candidate: Name, 

affiliation, address, telephone number, 

e-mail address, and current curriculum 

vitae. 

Nominations should be accompanied 

with a letter of recommendation stating 

the qualifications of the nominee and 

postmarked by March 20, 2009 to: 

Harriette Lynch, Coordinating Center for 

Infectious Diseases, Office of the 

Director, CDC, 1600 Clifton Road, NE., 

Mailstop E–77, Atlanta, Georgia 30333, 

Telephone (404) 498–2726. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: February 25, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–4475 Filed 3–2–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0606] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Export of Food and 

Drug Administration Regulated 

Products: Export Certificates 

AGENCY: Food and Drug Administration, 


HHS. 


ACTION: Notice. 


SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by April 2, 

2009. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–6974, or e-mailed to 

oira_submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–0498. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management (HFA–710), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–796–3794.